Rev Esp Cardiol (Engl Ed) . Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology

[tetano]

Rev Esp Cardiol (Engl Ed)


. 2020 Jun 19;S1885-5857(20)30272-3.
doi: 10.1016/j.rec.2020.04.025. Online ahead of print.
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology


[Article in En, Spanish]

David Vivas ¹ , Vanessa Rold?n ² , Mar?a Asunci?n Esteve-Pastor ³ , Inmaculada Rold?n ⁴ , Antonio Tello-Montoliu ³ , Juan Miguel Ruiz-Nodar ⁵ , Juan Cos?n-Sales ⁶ , Jos? Mar?a G?mez ⁷ , Luciano Consuegra ⁸ , Jos? Luis Ferreiro ⁹ , Francisco Mar?n ¹⁰ , Expert reviewers



Collaborators, Affiliations

• PMID: 32694078
• DOI: 10.1016/j.rec.2020.04.025

Abstract

The new coronavirus SARS-CoV-2, which gives rise to the highly contagious COVID-19 disease, has caused a pandemic that is overwhelming health care systems worldwide. Affected patients have been reported to have a heightened inflammatory state that increases their thrombotic risk. However, there is very scarce information on the management of thrombotic risk, coagulation disorders, and anticoagulant therapy. In addition, the situation has also greatly influenced usual care in patients not infected with COVID-19. This article by the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology aims to summarize the available information and to provide a practical approach to the management of antithrombotic therapy.

Keywords: Antithrombotics; Antitromb?ticos; COVID-19; Coronavirus; SARS-CoV-2; Thrombosis; Trombosis.